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The usefulness of tonsillar biopsy on live deer for preclinical diagnosis of the transmissible
spongiform encephalopathy chronic wasting disease (CWD) was evaluated. Disease was tracked in
a CWD-endemic herd using serial tonsillar biopsies collected at 6 to 9 month intervals from 34
captive mule deer (Odocoileus hemionus) and five white-tailed deer (O. virginianus). Tonsillar
biopsies were examined for accumulation of PrPCWD, the protein marker for infection, using
immunohistochemical (IHC) staining. 26/34 (76 %) mule deer and 4/5 (80 %) white-tailed deer had
PrPCWD accumulation in tonsillar biopsies ; CWD was subsequently confirmed by post-mortem
examination in all 30 of these tonsillar-positive deer. Six mule deer with IHC-negative tonsillar
biopsies had positive brain and tonsillar IHC staining upon death 12 to 40 months following the
last biopsy. PrPCWD accumulation in tonsillar biopsy was observed 2 to 20 months before CWDrelated death and up to 14 months before onset of clinical signs of CWD. Tonsillar biopsies from
3-month-old mule deer (n l 6) were IHC negative, but PrPCWD accumulation was detected in
tonsillar biopsies from 7/10 mule deer by 19 months of age. Tonsillar biopsy evaluated with IHC
staining is a useful technique for the preclinical diagnosis of CWD in live mule deer and white-tailed
deer when intensive management approaches are possible.

Introduction
Chronic wasting disease (CWD) is a naturally occurring
transmissible spongiform encephalopathy (TSE) of North
American deer (Odocoileus spp.) and elk (Cervus elaphus)
(Williams & Young, 1980, 1982). Like other TSEs, CWD is
identified by an accumulation of a characteristic partly
protease-resistant isoform of the prion protein, referred to as
PrPres or PrPCWD, in the brain of affected animals (Spraker et
al., 1997). Lymphoid accumulation of PrPCWD has been
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reported in mule deer (O. hemionus) with naturally occurring
CWD (Spraker et al., 2002a, b) and early lymphoid tropism of
PrPCWD has been documented following experimental oral
inoculation in mule deer (Sigurdson et al., 1999). Detection of
tonsillar PrPCWD by immunohistochemical (IHC) staining is
therefore a sensitive indicator of CWD infection.
In addition to application to post-mortem samples, IHC
staining of lymphoid tissue has been used as an ante-mortem
test to detect preclinical scrapie in sheep (Schreuder et al.,
1998 ; O’Rourke et al., 2000) and to diagnose variant CJD in
humans (Hill et al., 1999). Such a preclinical test for CWD could
greatly enhance epidemiological studies and potentially aid in
management activities where maintenance of live animals is
indicated. The objective of this study was to determine the
feasibility of using tonsillar biopsies obtained from captive
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mule deer and white-tailed deer (O. virginianus) as a preclinical
test for CWD. Serial tonsillar biopsies collected from mule deer
and white-tailed deer confirmed that PrPCWD accumulations
occur prior to onset of clinical CWD and can precede CWDrelated death by at least 20 months.

Methods
Animals. Thirty-four captive mule deer and five white-tailed deer
were sampled at a CWD-endemic site, the Colorado Division of Wildlifehs
Foothills Wildlife Research Facility (FWRF ; Fort Collins, CO, USA).
CWD has occurred in mule deer housed at the facility since at least 1967
(Williams & Young, 1992). Deer used in the study were females, males
and castrated males born at the facility or acquired from CWD-endemic
and non-endemic areas of Colorado (Miller et al., 2000). Deer were
maintained in 1 to 4 ha pastures and had ad libitum access to alfalfa hay,
a high-energy pelleted supplement (Baker et al., 1998), pelleted browser
supplement (Mazuri browser maintenance, PMI Feed), a trace mineral
block and water. Except for commercially obtained evaporated bovine
milk fed to some fawns, no ruminant-derived feed material was included
in any of the food sources. Sampled deer ranged in age from 3 months to
11 years. Most deer were more than 2 years of age when the biopsy
collection protocol was developed ; however, one cohort of ten mule deer
born in 1997 was sampled at 3, 10 and 19 months of age.
Sample collection. Serial tonsillar biopsies were collected from
mule deer at 6 to 9 month intervals between July 1996 and January 1999
and from white-tailed deer in April 1998. Deer were anaesthetized by
intramuscular administration of 5 to 12n5 mg\kg ketamine.HCl (Ketaset,
Fort Dodge Animal Health) combined with 1 to 2n5 mg\kg xylazine
(Cervizine, Wildlife Laboratories or Rompun, Bayer Corporation).
Alternatively, deer received 4 mg\kg Telazol (Fort Dodge Animal
Health) combined with 2 mg\kg xylazine. When anaesthetized, deer
were blindfolded and placed in sternal recumbency for sampling. The
mouth was held open with a metal mouth gag and the palatine tonsil
visualized using a laryngoscope with a 30 cm blade (Jorgensen
Laboratories). The biopsy was collected with a 30 cm Jackson endoscopic
forceps with 4 mm cup (Sontec Instruments, Inc.). The cup of the forceps
was placed in the tonsillar crypt and pressed against the ventral-medial
wall to obtain one to several tissue samples. Biopsy specimens were
placed in 10 % buffered neutral formalin. Deer were given prophylactic
antibiotics and analgesic. The mouth gag and blade of the laryngoscope
were wiped with 20 % bleach solution and rinsed in water. The Jackson
forceps was cleaned, soaked in 20 % bleach solution for 30 min, and then
rinsed in water.
Deer were euthanized after showing clinical signs of CWD or, in some
cases, died naturally with or without clinical signs of CWD. Brain, and in
most cases tonsil, was collected and formalin fixed to determine CWD
status by histology and IHC.
Immunohistochemical staining. Biopsy specimens were processed and embedded in paraffin blocks within 10 days of collection.
Tissue sections were mounted onto positively charged glass slides,
deparaffinized and hydrated in preparation for IHC. Tissue treatment
performed prior to IHC consisted of slide immersion in 88 % formic acid
solution for 5 min followed by a rinse in water. Tissue sections were then
autoclaved for 12 min at 121 mC in a buffer solution (DAKO target
antigen retrieval) and cooled for 30 min.
The IHC protocol employed an automated immunostainer (Ventana
Medical Systems) and PrP monoclonal antibody (mAb) F99\97.6.1, a
biotinylated secondary antibody, an alkaline phosphatase–streptavidin
conjugate, a substrate chromagen (fast red A), and a haematoxylin and
CGDA

bluing counterstain (Ventana Medical Systems). mAb F99\97.6.1 binds
residues 220–225 of the cervid PrP protein (QYQRES) (O’Rourke et al.,
2000) and has been validated for IHC staining of brain and tonsil in mule
deer (Spraker et al., 2002a). Positive and negative control deer brain and
tonsil sections were included in each run. CWD-negative deer were
harvested from the CWD non-endemic area (non-endemic area established by Miller et al., 2000) and were confirmed as CWD negative by
the absence of histological brain lesions and negative IHC staining for
PrPCWD in brain and tonsil.
Number of follicles staining positive (Spraker et al., 2002a) and total
number of intact tonsillar follicles were determined for each section.
Results were categorized into one of three interpretations based on
Schreuder et al. (1998) : positive (PrPCWD in any number of follicles),
negative (no detectable immunostaining in at least three follicles) or
inconclusive (less than three follicles in the sample with no detectable
immunostaining). We refer to biopsies where positive or negative
interpretation was possible as adequate samples.

Results
Tonsillar biopsy collection

Effectiveness of collecting tonsillar follicles in the biopsy
specimens varied greatly. Some samples yielded no follicles
while others produced  25. At least one adequate tonsillar
biopsy was collected from 34 mule deer and five white-tailed
deer. In early samplings, we failed to direct the biopsy
instrument to the ventral–medial aspect of the tonsillar crypt
and therefore collected many samples void of tonsillar
follicles ; these samples are excluded from the study. Otherwise,
success did not appear to vary over time, i.e. repeated sampling
of the tonsil did not appear to reduce successful collection of
follicles.
Immunohistochemical staining

Positive staining was characterized by coarse granular,
bright red material in lymphoid follicles (Fig. 1). With one
exception (Table 1, animal M92), all follicles within an
individual biopsy stained uniformly either positive or negative.
No staining was seen in negative control samples from deer
harvested outside the CWD-endemic area.
Clinical and post-mortem findings

All deer used in this study had died by February 2001.
Overall, 32\34 (94 %) mule deer and 4\5 (80 %) white-tailed
deer were infected with CWD. Thirty mule deer and three
white-tailed deer died, or were euthanized at varying stages
during the clinical course of CWD. Clinical signs observed in
these deer included weight loss, behavioural change, depression, excessive salivation, excessive oesophageal reflux
and polyuria\polydipsia (Williams & Young, 1992). Date of
onset of CWD clinical signs was recorded for 12 mule deer and
two white-tailed deer. Clinical signs of CWD were usually
observed 1 to 4 months prior to euthanasia or death ; however,
two mule deer exhibited prolonged clinical presentations of 9
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Fig. 1. Tonsillar biopsy collected from CWD-positive (a) and negative (b) captive mule deer as determined by IHC using antiPrP monoclonal antibody 99/97.6.1. Dark granular red immunostain is apparent in the lymphoid follicles (arrows) of the CWDpositive deer but not the negative deer.

and 13 months (Table 1). Appearance of clinical signs of CWD
followed positive IHC staining of tonsillar biopsy by up to 14
months (Table 1).
CWD was confirmed by post-mortem examination of brain
in all mule deer (n l 30) and white-tailed deer (n l 3) with
clinical signs indicative of CWD. All deer with confirmed
CWD for which tonsil samples were available (n l 28) showed
positive immunostaining in tonsil tissue collected postmortem. Two mule deer and one white-tailed deer that died or
were euthanized without clinical signs of CWD were IHC
positive on post-mortem examination of brain. The remaining
two mule deer and one white-tailed deer were IHC negative on
tonsillar biopsy and on post-mortem examination of brain.
Live animal testing

Ten mule deer had positive tonsillar IHC when first sampled
(Table 1, group a) at ages ranging from 10 to 64 months. Those
ten deer died or were euthanized with clinical signs of CWD 2
to 20 months after sampling (Fig. 2, group a). CWD was
confirmed post-mortem by examination of brain and tonsillar
tissue in all ten of these deer.
Sixteen mule deer converted from negative to positive IHC
staining on biopsy samples over the 3 year sampling period
(Table 1, group b). Once an IHC-positive biopsy was obtained
from an individual, all subsequent biopsies from that individual
were positive. Age at initial biopsy ranged from 3 to 128
months and the interval from the last negative biopsy sample
to the first positive biopsy sample ranged from 6 to 23 months.
All 16 deer died or were euthanized with clinical CWD at ages
28 to 145 months, 6 to 19 months after the first IHC-positive
tonsillar biopsy (Fig. 2, group b).

Six mule deer with negative biopsy samples (Table 1, group
c) died or were euthanized 12 to 40 months after the last
biopsy collection at ages ranging from 31 to 80 months. Death
occurred 27 to 55 months after the first biopsy sampling. Two
of these deer (Table 1, C92 and J93) died due to causes other
than CWD ; however, CWD was confirmed in all six deer by
post-mortem IHC analysis of the brain. Tonsil samples
collected post-mortem from each deer were also IHC positive.
Two mule deer remained negative throughout (Table 1,
group d). These deer died or were euthanized due to causes
other than CWD 7 and 13 months after the first biopsy was
obtained. Deer were age 11 and 98 months at death.
Of the 34 mule deer sampled, ten were members of a cohort
born in 1997. These deer were evaluated by sequential
sampling at 3, 10 and 19 months of age, although not all
samplings yielded adequate biopsy samples. None of the six
deer from which adequate tonsillar biopsies were collected at 3
months of age were IHC positive. Seven of the ten deer had at
least one positive tonsillar biopsy by 19 months of age : 2\7
deer successfully sampled at 10 months and an additional 5\5
deer successfully sampled at 19 months of age were tonsillar
IHC positive. The remaining three deer were test negative at
3 and 10 months and no adequate sample was collected at 19
months. One of these deer died at 11 months of age from nonCWD related causes while the remaining nine all died from
CWD at ages 26 to 42 months.
White-tailed deer were 58 months of age at sampling. Four
of five white-tailed deer had IHC-positive tonsillar biopsy.
CWD was confirmed in all four deer at death 2 to 18 months
after sampling. One of these deer had not exhibited clinical
signs of CWD when it was euthanized for non-CWD related
causes 18 months following a positive tonsillar biopsy. The
CGDB
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Table 1. Age of mule deer at onset of clinical signs of CWD, first and last IHC-negative tonsillar biopsy, first positive
tonsillar biopsy and death.
Biopsy groups : a, IHC positive on first biopsy ; b, IHC-negative biopsy followed by IHC-positive biopsy, c, IHC-negative biopsy followed by
CWD-positive brain post-mortem ; d, IHC-negative biopsy and CWD-negative brain post-mortem.
, Not applicable ; Unk., unknown.
Age (months) on :
Animal ID
Ea93
K92
L94
M92
N92
Ra397
Rb91
Rc91
Sa97
Y92
B93
Db97
F92
G92
H92
Ma97
Mb97
O92
R193
Rb697
V92
W92
W97
X92
Y86
Za93
C92*
Da97
J93*
Sb97
T94
Z93
Ra697
Z89

Group

Clinical
CWD

First negative
biopsy

Last negative
biopsy

First positive
biopsy

Death

a
a
a
a
a
a
a
a
a
a
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
c
c
c
c
c
c
d
d

40
63
40
Unk
70
Unk.
69
69
Unk.
58
Unk.
Unk.
58
Unk.
Unk.
Unk.
Unk.
Unk.
Unk.
Unk.
Unk.
74
Unk.
69
144
Unk.

Unk.

Unk.
Unk.
55













37
3
49
64
64
10
10
49
37
3
56
49
3
49
128
37
56
3
37
3
25
52
3
85











52
3
49
64
70
10
10
49
44
10
56
49
3
56
128
44
56
10
52
10
40
52
3
92

37
56
32
64
56
10
61
61
19
56
58
19
64
70
79
19
19
64
67
19
70
70
10
64
136
58









42
66
44
84
72
26
70
70
36
58
72
37
71
85
88
32
28
82
74
38
85
76
29
73
145
69
76
31
66
42
80
64
11
98

* Deer died of causes unrelated to CWD, but was IHC positive on brain post-mortem.

deer that was negative on tonsillar biopsy was CWD-negative
on post-mortem examination of brain when it was euthanized
for non-CWD related causes 18 months after sampling.

Discussion
Accumulation of PrPCWD in lymphoid tissue has been
documented post-mortem in mule deer with experimental
CWD infections (Sigurdson et al., 1999) and in mule deer
(Spraker et al., 2002a, b) and white-tailed deer (T. R. Spraker,
CGDC

unpublished data) with natural CWD infections. In mule deer
experimentally inoculated orally with CWD-positive brain
material, PrPCWD accumulation was observed in tonsils prior
to brain and as early as 78 days post-inoculation (Sigurdson et
al., 1999). In our study, tonsillar biopsy provided a means for
the preclinical diagnosis of CWD in live mule deer and whitetailed deer. PrPCWD accumulation in ante-mortem tonsillar
biopsy samples was documented in 26\32 (81 %) mule deer
and 4\4 (100 %) white-tailed deer subsequently diagnosed
with CWD. Although rare, lack of lymphoid accumulation of
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Fig. 2. Time between first IHC-positive tonsillar biopsy and CWD-related death in captive mule deer in cases where initial
tonsillar biopsy was IHC positive (group a ; grey bar) and cases that converted from IHC negative to positive on tonsillar biopsy
(group b ; black bar).

PrPCWD has been reported in mule deer with CWD (Spraker et
al., 2002a) ; however, all CWD-infected deer in this study had
accumulation of PrPCWD in tonsil at the time of post-mortem
examination. Negative findings in six mule deer that subsequently died with CWD 12 to 40 months after the last
negative sampling may have been due to inadequate biopsy
sample size or sampling too early in the disease course.
Follicles within a biopsy stained uniformly either all positive or
all negative in 74\75 (99 %) of the adequate samples ; therefore
it is unlikely that positive cases were misdiagnosed in serial
sampling of these captive deer. However, deer will test IHC
negative on tonsillar biopsy samples early in disease progression, before lymphoid accumulation begins (Sigurdson et
al., 1999). Therefore, negative tonsillar biopsy does not assure
that deer are free of infection.
Although biopsy collection was primarily from adult deer,
one cohort of young mule deer born at this CWD-endemic
facility was followed and provided insight into early exposure
to CWD. All biopsies (n l 6) collected at 3 months of age
were negative. The youngest deer to test IHC positive were
two 10-month-old mule deer. Five other mule deer tested IHC
positive at 19 months of age.
PrPCWD accumulation in tonsillar biopsies was documented
up to 20 months prior to death and 14 months prior to onset
of clinical signs of CWD (Table 1). However, the period of
preclinical lymphoid accumulation of PrPCWD in our study was
likely underestimated in some cases due to the time lapse
between sample collections and because we sampled primarily
adult deer. Many adult deer may have had disease exposure
and progression prior to initiation of biopsy sampling. In fact,
5\8 mule deer with IHC-positive tonsillar biopsies  16
months prior to death (Table 1) were from the 1997 cohort, the
only deer that we began sampling as juveniles. Therefore,
reported preclinical periods should be considered minimum
estimates in these captive deer.

Although use of the 4 mm Jackson endoscopic forceps was
adequate for collection of biopsies in many cases, a modified
technique that more reliably obtains numerous tonsillar follicles
in the biopsy should be developed for highest efficiency.
Availability of an affordable disposable biopsy instrument also
would be useful to minimize the risk of unintentional PrPCWD
transmission. Although we believed that our inactivation
technique for surgical instruments was adequate, recent
research underscores the difficulty in fully inactivating PrPres
(Taylor, 2000), particularly on stainless steel surgical instruments (Zobeley et al., 1999). Although we cannot exclude the
possibility that iatrogenic transmission occurred, high rates of
CWD in deer used in our study (94 % in mule deer and 80 % in
white-tailed deer) should not be regarded as evidence that
cross-contamination from the biopsy technique occurred. From
1970 to 1981, 90 % of mule deer that were resident at this same
facility for 2 years or longer developed CWD (Williams &
Young, 1992). In our study, the mean interval from first biopsy
collection to death from CWD in deer with negative initial
samples was 36 months (SD l 7 months) for deer ranging in
age from 3 to 128 months at sampling. In a group of nonbiopsied mule deer (n l 8) held at this facility concurrently,
mean time from arrival at the facility to death from CWD was
also 36 months (M. W. Miller, unpublished data).
Tonsillar biopsy was successful in identifying CWDaffected live deer, in most cases well before the onset of clinical
signs of the disease. Although few white-tailed deer were
available for biopsy, findings were consistent with those in
mule deer and support similarity in lymphoid accumulation
of PrPCWD between the species that has been observed postmortem. However, because PrPCWD does not appear to
accumulate in lymphoid tissue to the same degree in elk as deer
(T. R. Spraker, unpublished data), the technique is not currently
applicable to elk. However, where intensive management
actions are possible, use of this technique will aid in the clinical
CGDD
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diagnosis of CWD in individual captive or free-ranging deer
and in epidemiological investigations of CWD in populations
of mule deer and white-tailed deer.
This study was funded by the Colorado Division of Wildlife and
Federal Aid in Wildlife Restoration Project W-153-R. E. A. Wheeler,
P. E. Bleicher, A. Case, and numerous other CDOW personnel provided
excellent animal care and sampling assistance. Lee Debuse, Robert Zink
and Bruce Cummings performed histological preparations and IHC
assays. Gary Miller, Chad Bishop, Jim Gammonley and two anonymous
reviewers provided helpful comments on an earlier draft of this
manuscript.

References
Baker, D. L., Stout, G. W. & Miller, M. W. (1998). A diet supplement for

captive wild ruminants. Journal of Zoo and Wildlife Medicine 29, 150–156.
Hill, A. F., Butterworth, R. J., Joiner, S., Jackson, G., Rossor, M. N.,
Thomas, D. J., Bell, J. E., Spencer, M., King, A., Al-Sarraj, S., Ironside,
J. W. & Collinge, J. (1999). Investigation of variant Creutzfeldt–Jakob

disease and other human prion diseases with tonsil biopsy samples. Lancet
353, 183–189.
Miller, M. W., Williams, E. S., McCarty, C. W., Spraker, T. R., Kreeger,
T. J., Larsen, C. T. & Thorne, E. T. (2000). Epizootiology of chronic

wasting disease in free-ranging cervids in Colorado and Wyoming.
Journal of Wildlife Diseases 36, 676–690.
O’Rourke, K. I., Baszler, T. V., Besser, T. E., Miller, J. M., Cutlip, R. C.,
Wells, G. A. H., Ryder, S. J., Parish, S. M., Hamir, A. N., Cockett, N. E.,
Jenny, A. & Knowles, D. P. (2000). Preclinical diagnosis of scrapie by

immunohistochemistry of third eyelid lymphoid tissues. Journal of Clinical
Microbiology 38, 3254–3259.
Schreuder, B. E. C., van Keulen, L. J. M., Vromans, M. E. W.,
Langeveld, J. P. M. & Smits, M. A. (1998). Tonsillar biopsy and PrPSc

detection in the preclinical diagnosis of scrapie. Veterinary Record 142,
564–568.

CGDE

Sigurdson, C. J., Williams, E. S., Miller, M. W., Spraker, T. R., O’Rourke,
K. I. & Hoover, E. A. (1999). Oral transmission and early lymphoid

tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus
hemionus). Journal of General Virology 80, 2757–2764.
Spraker, T. R., Miller, M. W., Williams, E. S., Getzy, D. M., Adrian,
W. J., Schoonveld, G. G., Spowart, R. A., O’Rourke, K. I., Miller, J. M. &
Merz, P. A. (1997). Spongiform encephalopathy in free-ranging mule

deer (Odocoileus hemionus), white-tailed deer (Odocoileus virginianus) and
Rocky Mountain elk (Cervus elaphus nelsoni) in northcentral Colorado.
Journal of Wildlife Diseases 33, 1–6.
Spraker, T. R., O’Rourke, K. I., Balachandran, A., Zink, R. R.,
Cummings, B. A., Miller, M. W. & Powers, B. E. (2002a). Validation of

monoclonal antibody F99\97.6.1 for immunohistochemical staining of
brain and tonsil in mule deer (Odocoileus hemionus) with chronic wasting
disease. Journal of Veterinary Diagnostic Investigation 14, 3–7.
Spraker, T. R., Zink, R. R., Cummings, B. A., Wild, M. A., Miller, M. W.
& O’Rourke, K. I. (2002b). Comparison of histological lesions and

immunohistochemical staining of protease-resistant prion protein in a
naturally-occurring spongiform encephalopathy of free-ranging mule
deer (Odocoileus hemionus) with those of chronic wasting disease of
captive mule deer. Veterinary Pathology 39, 110–119.
Taylor, D. M. (2000). Inactivation of transmissible degenerative encephalopathy agents : a review. Veterinary Journal 159, 10–17.
Williams, E. S. & Young, S. (1980). Chronic wasting disease of captive
mule deer : a spongiform encephalopathy. Journal of Wildlife Diseases 16,
89–98.
Williams, E. S. & Young, S. (1982). Spongiform encephalopathy of
Rocky Mountain elk. Journal of Wildlife Diseases 18, 465–471.
Williams, E. S. & Young, S. (1992). Spongiform encephalopathies in
Cervidae. Revue Scientifique et Technique Office International des Epizooties
11, 551–567.
Zobeley, E., Flechsig, E., Cozzio, A., Enari, M. & Weissmann, C.
(1999). Infectivity of scrapie prions bound to a stainless steel surface.

Molecular Medicine 5, 240–243.
Received 26 April 2002 ; Accepted 3 July 2002

